Adjuvant whole abdominal intensity modulated radiotherapy (IMRT) for high risk stage FIGO III patients with ovarian cancer (OVAR-IMRT-01) – Pilot trial of a phase I/II study: study protocol

Bibliographic Details
Main Authors: Rochet, Nathalie, Jensen, Alexandra D, Sterzing, Florian, Munter, Marc W, Eichbaum, Michael H, Schneeweiss, Andreas, Sohn, Christof, Debus, Juergen, Harms, Wolfgang
Format: Online
Language:English
Published: BioMed Central 2007
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2212657/
id pubmed-2212657
recordtype oai_dc
spelling pubmed-22126572008-01-24 Adjuvant whole abdominal intensity modulated radiotherapy (IMRT) for high risk stage FIGO III patients with ovarian cancer (OVAR-IMRT-01) – Pilot trial of a phase I/II study: study protocol Rochet, Nathalie Jensen, Alexandra D Sterzing, Florian Munter, Marc W Eichbaum, Michael H Schneeweiss, Andreas Sohn, Christof Debus, Juergen Harms, Wolfgang Study Protocol BioMed Central 2007-12-19 /pmc/articles/PMC2212657/ /pubmed/18093313 http://dx.doi.org/10.1186/1471-2407-7-227 Text en Copyright © 2007 Rochet et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
repository_type Open Access Journal
institution_category Foreign Institution
institution US National Center for Biotechnology Information
building NCBI PubMed
collection Online Access
language English
format Online
author Rochet, Nathalie
Jensen, Alexandra D
Sterzing, Florian
Munter, Marc W
Eichbaum, Michael H
Schneeweiss, Andreas
Sohn, Christof
Debus, Juergen
Harms, Wolfgang
spellingShingle Rochet, Nathalie
Jensen, Alexandra D
Sterzing, Florian
Munter, Marc W
Eichbaum, Michael H
Schneeweiss, Andreas
Sohn, Christof
Debus, Juergen
Harms, Wolfgang
Adjuvant whole abdominal intensity modulated radiotherapy (IMRT) for high risk stage FIGO III patients with ovarian cancer (OVAR-IMRT-01) – Pilot trial of a phase I/II study: study protocol
author_facet Rochet, Nathalie
Jensen, Alexandra D
Sterzing, Florian
Munter, Marc W
Eichbaum, Michael H
Schneeweiss, Andreas
Sohn, Christof
Debus, Juergen
Harms, Wolfgang
author_sort Rochet, Nathalie
title Adjuvant whole abdominal intensity modulated radiotherapy (IMRT) for high risk stage FIGO III patients with ovarian cancer (OVAR-IMRT-01) – Pilot trial of a phase I/II study: study protocol
title_short Adjuvant whole abdominal intensity modulated radiotherapy (IMRT) for high risk stage FIGO III patients with ovarian cancer (OVAR-IMRT-01) – Pilot trial of a phase I/II study: study protocol
title_full Adjuvant whole abdominal intensity modulated radiotherapy (IMRT) for high risk stage FIGO III patients with ovarian cancer (OVAR-IMRT-01) – Pilot trial of a phase I/II study: study protocol
title_fullStr Adjuvant whole abdominal intensity modulated radiotherapy (IMRT) for high risk stage FIGO III patients with ovarian cancer (OVAR-IMRT-01) – Pilot trial of a phase I/II study: study protocol
title_full_unstemmed Adjuvant whole abdominal intensity modulated radiotherapy (IMRT) for high risk stage FIGO III patients with ovarian cancer (OVAR-IMRT-01) – Pilot trial of a phase I/II study: study protocol
title_sort adjuvant whole abdominal intensity modulated radiotherapy (imrt) for high risk stage figo iii patients with ovarian cancer (ovar-imrt-01) – pilot trial of a phase i/ii study: study protocol
description
publisher BioMed Central
publishDate 2007
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2212657/
_version_ 1611434320944168960